Dual Biomarkers Improve Cervical Cancer Screening
How p16 and Ki-67 indicate transforming HPV infections.
Read MorePosted by Melanie Hamilton-Basich | May 3, 2021 | Cervical (HPV) |
How p16 and Ki-67 indicate transforming HPV infections.
Read MorePosted by Melanie Hamilton-Basich | Feb 19, 2021 | Colorectal, Research |
The study suggests that such liquid biopsies could help personalize treatment for oligometastatic colorectal cancer.
Read MorePosted by Melanie Hamilton-Basich | Feb 12, 2021 | Prostate |
The study validated the Decipher RP test as an independent predictor of distant metastases, prostate cancer-specific mortality, and overall survival.
Read MorePosted by Laurie Bonner | Oct 28, 2020 | Cancer, POC Instruments |
The handheld device works much like blood sugar monitors and can be used at home to measure a biomarker for cancer.
Read MorePosted by Melanie Hamilton-Basich | Oct 27, 2020 | Breast, Lung Cancer, Unknown Origin & Other Cancer Types |
FDA approved FoundationOne Liquid CDx for three new companion diagnostic indications: Piqray in advanced or metastatic breast cancer; Rubraca in advanced ovarian cancer; and Alecensa in a certain type of metastatic non-small cell lung cancer.
Read More